Position in RPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$44,739,220
+$14,201,951 QoQ
Shares Held
932,650
+18.0% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. RPRX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,739,220 | 932,650 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,537,269 | 790,302 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $28,465,738 | 806,852 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $26,699,527 | 741,036 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,712,944 | 279,889 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,356,360 | 209,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,974,253 | 211,179 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,527,623 | 171,696 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,389,672 | 177,467 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,646,784 | 129,825 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,333,361 | 122,821 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,899,679 | 842,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,375,428 | 870,814 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,216,452 | 1,144,141 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,238,664 | 677,916 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,124,712 | 98,114 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,560,359 | 91,385 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,030,158 | 50,945 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $103,704 | 2,530 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,391,478 | 31,900 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $578,377 | 11,556 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $70,467 | 1,675 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||